 | • レポートコード：MRC23Q36785 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥406,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥812,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のブロモドメイン含有タンパク質 3市場について調査・分析し、世界のブロモドメイン含有タンパク質 3市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（RING3ライクプロテイン、BRD3）、用途別セグメント分析（腫瘍学、皮膚科、免疫学、筋骨格系疾患）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AbbVie Inc、Amgen Inc、Boehringer Ingelheim International GmbH、Bristol-Myers Squibb Co、Constellation Pharmaceuticals Inc、Ningbo Wenda Pharmaceutical Technology Co Ltd、Roivant Sciences Ltd、Zenith Epigenetics Ltdなどが含まれています。世界のブロモドメイン含有タンパク質 3市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ブロモドメイン含有タンパク質 3市場規模を推定する際に考慮しました。本レポートは、ブロモドメイン含有タンパク質 3の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ブロモドメイン含有タンパク質 3に関するビジネス上の意思決定に役立てることを目的としています。 ・ブロモドメイン含有タンパク質 3市場の概要 - 製品の定義 - ブロモドメイン含有タンパク質 3のタイプ別セグメント - 世界のブロモドメイン含有タンパク質 3市場規模：タイプ別分析（RING3ライクプロテイン、BRD3） - ブロモドメイン含有タンパク質 3の用途別セグメント - 世界のブロモドメイン含有タンパク質 3市場規模：用途別分析（腫瘍学、皮膚科、免疫学、筋骨格系疾患） - 世界のブロモドメイン含有タンパク質 3市場規模予測（2018年-2029年） - ブロモドメイン含有タンパク質 3の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ブロモドメイン含有タンパク質 3市場の競争状況およびトレンド ・ブロモドメイン含有タンパク質 3の地域別市場規模 - 北米のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - アメリカのブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - ヨーロッパのブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - アジア太平洋のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - 中国のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - 日本のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - 韓国のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - インドのブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - オーストラリアのブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - 中南米のブロモドメイン含有タンパク質 3市場規模（2018年-2029年） - 中東・アフリカのブロモドメイン含有タンパク質 3市場規模（2018年-2029年） ・タイプ別セグメント：RING3ライクプロテイン、BRD3 - 世界のブロモドメイン含有タンパク質 3のタイプ別販売量（2018年-2023年） - 世界のブロモドメイン含有タンパク質 3のタイプ別売上（2018年-2023年） - 世界のブロモドメイン含有タンパク質 3のタイプ別価格 ・用途別セグメント：腫瘍学、皮膚科、免疫学、筋骨格系疾患 - 世界のブロモドメイン含有タンパク質 3の用途別販売量（2018年-2023年） - 世界のブロモドメイン含有タンパク質 3の用途別売上（2018年-2023年） - 世界のブロモドメイン含有タンパク質 3の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 AbbVie Inc、Amgen Inc、Boehringer Ingelheim International GmbH、Bristol-Myers Squibb Co、Constellation Pharmaceuticals Inc、Ningbo Wenda Pharmaceutical Technology Co Ltd、Roivant Sciences Ltd、Zenith Epigenetics Ltd ・産業チェーンと販売チャネルの分析 - ブロモドメイン含有タンパク質 3産業チェーン分析 - ブロモドメイン含有タンパク質 3の主要原材料 - ブロモドメイン含有タンパク質 3の販売チャネル - ブロモドメイン含有タンパク質 3のディストリビューター - ブロモドメイン含有タンパク質 3の主要顧客 ・ブロモドメイン含有タンパク質 3市場ダイナミクス - ブロモドメイン含有タンパク質 3の業界動向 - ブロモドメイン含有タンパク質 3市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) – Bromodomain-containing protein 3 (BRD3) or RING3-like protein (RING3L) is a protein that encodes the BRD3 gene. It plays a role in the regulation of transcription, probably by chromatin remodeling and interaction with transcription factors. It regulates transcription by promoting the binding of the transcription factor GATA1 to its targets. The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 2, 3 and 3 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Highlights
The global Bromodomain Containing Protein 3 market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bromodomain Containing Protein 3 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bromodomain Containing Protein 3 is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bromodomain Containing Protein 3 include AbbVie Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co, Constellation Pharmaceuticals Inc, Ningbo Wenda Pharmaceutical Technology Co Ltd, Roivant Sciences Ltd and Zenith Epigenetics Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bromodomain Containing Protein 3, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bromodomain Containing Protein 3.
The Bromodomain Containing Protein 3 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bromodomain Containing Protein 3 market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bromodomain Containing Protein 3 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AbbVie Inc
Amgen Inc
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Co
Constellation Pharmaceuticals Inc
Ningbo Wenda Pharmaceutical Technology Co Ltd
Roivant Sciences Ltd
Zenith Epigenetics Ltd
Segment by Type
RING3 Like Protein
BRD3
Segment by Application
Oncology
Dermatology
Immunology
Musculoskeletal Disorders
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bromodomain Containing Protein 3 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bromodomain Containing Protein 3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bromodomain Containing Protein 3 Market Overview
1.1 Product Overview and Scope of Bromodomain Containing Protein 3
1.2 Bromodomain Containing Protein 3 Segment by Type
1.2.1 Global Bromodomain Containing Protein 3 Market Value Comparison by Type (2023-2029)
1.2.2 RING3 Like Protein
1.2.3 BRD3
1.3 Bromodomain Containing Protein 3 Segment by Application
1.3.1 Global Bromodomain Containing Protein 3 Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Dermatology
1.3.4 Immunology
1.3.5 Musculoskeletal Disorders
1.4 Global Bromodomain Containing Protein 3 Market Size Estimates and Forecasts
1.4.1 Global Bromodomain Containing Protein 3 Revenue 2018-2029
1.4.2 Global Bromodomain Containing Protein 3 Sales 2018-2029
1.4.3 Global Bromodomain Containing Protein 3 Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bromodomain Containing Protein 3 Market Competition by Manufacturers
2.1 Global Bromodomain Containing Protein 3 Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bromodomain Containing Protein 3 Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bromodomain Containing Protein 3 Average Price by Manufacturers (2018-2023)
2.4 Global Bromodomain Containing Protein 3 Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bromodomain Containing Protein 3, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bromodomain Containing Protein 3, Product Type & Application
2.7 Bromodomain Containing Protein 3 Market Competitive Situation and Trends
2.7.1 Bromodomain Containing Protein 3 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bromodomain Containing Protein 3 Players Market Share by Revenue
2.7.3 Global Bromodomain Containing Protein 3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bromodomain Containing Protein 3 Retrospective Market Scenario by Region
3.1 Global Bromodomain Containing Protein 3 Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bromodomain Containing Protein 3 Global Bromodomain Containing Protein 3 Sales by Region: 2018-2029
3.2.1 Global Bromodomain Containing Protein 3 Sales by Region: 2018-2023
3.2.2 Global Bromodomain Containing Protein 3 Sales by Region: 2024-2029
3.3 Global Bromodomain Containing Protein 3 Global Bromodomain Containing Protein 3 Revenue by Region: 2018-2029
3.3.1 Global Bromodomain Containing Protein 3 Revenue by Region: 2018-2023
3.3.2 Global Bromodomain Containing Protein 3 Revenue by Region: 2024-2029
3.4 North America Bromodomain Containing Protein 3 Market Facts & Figures by Country
3.4.1 North America Bromodomain Containing Protein 3 Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bromodomain Containing Protein 3 Sales by Country (2018-2029)
3.4.3 North America Bromodomain Containing Protein 3 Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bromodomain Containing Protein 3 Market Facts & Figures by Country
3.5.1 Europe Bromodomain Containing Protein 3 Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bromodomain Containing Protein 3 Sales by Country (2018-2029)
3.5.3 Europe Bromodomain Containing Protein 3 Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bromodomain Containing Protein 3 Market Facts & Figures by Country
3.6.1 Asia Pacific Bromodomain Containing Protein 3 Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bromodomain Containing Protein 3 Sales by Country (2018-2029)
3.6.3 Asia Pacific Bromodomain Containing Protein 3 Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bromodomain Containing Protein 3 Market Facts & Figures by Country
3.7.1 Latin America Bromodomain Containing Protein 3 Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bromodomain Containing Protein 3 Sales by Country (2018-2029)
3.7.3 Latin America Bromodomain Containing Protein 3 Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bromodomain Containing Protein 3 Market Facts & Figures by Country
3.8.1 Middle East and Africa Bromodomain Containing Protein 3 Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bromodomain Containing Protein 3 Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bromodomain Containing Protein 3 Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bromodomain Containing Protein 3 Sales by Type (2018-2029)
4.1.1 Global Bromodomain Containing Protein 3 Sales by Type (2018-2023)
4.1.2 Global Bromodomain Containing Protein 3 Sales by Type (2024-2029)
4.1.3 Global Bromodomain Containing Protein 3 Sales Market Share by Type (2018-2029)
4.2 Global Bromodomain Containing Protein 3 Revenue by Type (2018-2029)
4.2.1 Global Bromodomain Containing Protein 3 Revenue by Type (2018-2023)
4.2.2 Global Bromodomain Containing Protein 3 Revenue by Type (2024-2029)
4.2.3 Global Bromodomain Containing Protein 3 Revenue Market Share by Type (2018-2029)
4.3 Global Bromodomain Containing Protein 3 Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bromodomain Containing Protein 3 Sales by Application (2018-2029)
5.1.1 Global Bromodomain Containing Protein 3 Sales by Application (2018-2023)
5.1.2 Global Bromodomain Containing Protein 3 Sales by Application (2024-2029)
5.1.3 Global Bromodomain Containing Protein 3 Sales Market Share by Application (2018-2029)
5.2 Global Bromodomain Containing Protein 3 Revenue by Application (2018-2029)
5.2.1 Global Bromodomain Containing Protein 3 Revenue by Application (2018-2023)
5.2.2 Global Bromodomain Containing Protein 3 Revenue by Application (2024-2029)
5.2.3 Global Bromodomain Containing Protein 3 Revenue Market Share by Application (2018-2029)
5.3 Global Bromodomain Containing Protein 3 Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Corporation Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AbbVie Inc Bromodomain Containing Protein 3 Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Amgen Inc
6.2.1 Amgen Inc Corporation Information
6.2.2 Amgen Inc Description and Business Overview
6.2.3 Amgen Inc Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amgen Inc Bromodomain Containing Protein 3 Product Portfolio
6.2.5 Amgen Inc Recent Developments/Updates
6.3 Boehringer Ingelheim International GmbH
6.3.1 Boehringer Ingelheim International GmbH Corporation Information
6.3.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.3.3 Boehringer Ingelheim International GmbH Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim International GmbH Bromodomain Containing Protein 3 Product Portfolio
6.3.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.4 Bristol-Myers Squibb Co
6.4.1 Bristol-Myers Squibb Co Corporation Information
6.4.2 Bristol-Myers Squibb Co Description and Business Overview
6.4.3 Bristol-Myers Squibb Co Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Co Bromodomain Containing Protein 3 Product Portfolio
6.4.5 Bristol-Myers Squibb Co Recent Developments/Updates
6.5 Constellation Pharmaceuticals Inc
6.5.1 Constellation Pharmaceuticals Inc Corporation Information
6.5.2 Constellation Pharmaceuticals Inc Description and Business Overview
6.5.3 Constellation Pharmaceuticals Inc Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Constellation Pharmaceuticals Inc Bromodomain Containing Protein 3 Product Portfolio
6.5.5 Constellation Pharmaceuticals Inc Recent Developments/Updates
6.6 Ningbo Wenda Pharmaceutical Technology Co Ltd
6.6.1 Ningbo Wenda Pharmaceutical Technology Co Ltd Corporation Information
6.6.2 Ningbo Wenda Pharmaceutical Technology Co Ltd Description and Business Overview
6.6.3 Ningbo Wenda Pharmaceutical Technology Co Ltd Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ningbo Wenda Pharmaceutical Technology Co Ltd Bromodomain Containing Protein 3 Product Portfolio
6.6.5 Ningbo Wenda Pharmaceutical Technology Co Ltd Recent Developments/Updates
6.7 Roivant Sciences Ltd
6.6.1 Roivant Sciences Ltd Corporation Information
6.6.2 Roivant Sciences Ltd Description and Business Overview
6.6.3 Roivant Sciences Ltd Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roivant Sciences Ltd Bromodomain Containing Protein 3 Product Portfolio
6.7.5 Roivant Sciences Ltd Recent Developments/Updates
6.8 Zenith Epigenetics Ltd
6.8.1 Zenith Epigenetics Ltd Corporation Information
6.8.2 Zenith Epigenetics Ltd Description and Business Overview
6.8.3 Zenith Epigenetics Ltd Bromodomain Containing Protein 3 Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Zenith Epigenetics Ltd Bromodomain Containing Protein 3 Product Portfolio
6.8.5 Zenith Epigenetics Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bromodomain Containing Protein 3 Industry Chain Analysis
7.2 Bromodomain Containing Protein 3 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bromodomain Containing Protein 3 Production Mode & Process
7.4 Bromodomain Containing Protein 3 Sales and Marketing
7.4.1 Bromodomain Containing Protein 3 Sales Channels
7.4.2 Bromodomain Containing Protein 3 Distributors
7.5 Bromodomain Containing Protein 3 Customers
8 Bromodomain Containing Protein 3 Market Dynamics
8.1 Bromodomain Containing Protein 3 Industry Trends
8.2 Bromodomain Containing Protein 3 Market Drivers
8.3 Bromodomain Containing Protein 3 Market Challenges
8.4 Bromodomain Containing Protein 3 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer